Cargando…
Identification and Characterization of Amlexanox as a G Protein-Coupled Receptor Kinase 5 Inhibitor
G protein-coupled receptor kinases (GRKs) have been implicated in human diseases ranging from heart failure to diabetes. Previous studies have identified several compounds that selectively inhibit GRK2, such as paroxetine and balanol. Far fewer selective inhibitors have been reported for GRK5, a tar...
Autores principales: | Homan, Kristoff T., Wu, Emily, Cannavo, Alessandro, Koch, Walter J., Tesmer, John J. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621012/ https://www.ncbi.nlm.nih.gov/pubmed/25340299 http://dx.doi.org/10.3390/molecules191016937 |
Ejemplares similares
-
Molecular Basis for Small Molecule Inhibition of G
Protein-Coupled Receptor Kinases
por: Homan, Kristoff T., et al.
Publicado: (2014) -
Identification and Structure–Function Analysis
of Subfamily Selective G Protein-Coupled Receptor Kinase Inhibitors
por: Homan, Kristoff T., et al.
Publicado: (2014) -
G Protein-Coupled Receptor Kinase 2 (GRK2) and 5 (GRK5)
Exhibit Selective Phosphorylation of the Neurotensin Receptor in Vitro
por: Inagaki, Sayaka, et al.
Publicado: (2015) -
G Protein-Coupled Receptor and Their Kinases in Cell Biology and Disease
por: Cannavo, Alessandro
Publicado: (2022) -
Special Issue: “G Protein-Coupled Receptor and Their Kinases in Cell Biology and Disease 2.0”
por: Cannavo, Alessandro
Publicado: (2022)